Chronic Mucosal Inflammation in Pediatric Intestinal Failure Patients—A Unique Phenomenon

Introduction/Objectives: As intestinal failure (IF) management improves and long-term survival rate increases, its physiological complications have become more apparent. The development of chronic intestinal inflammation resembling inflammatory bowel disease (IBD) in this population has been reported, but the literature describing it in detail is sparse. The present study was designed to characterize children with IF who developed chronic intestinal inflammation and identify the potential predisposing clinical factors. Methods: This retrospective study was based on the electronic medical records of pediatric patients seen at the Cincinnati Children’s Hospital Medical Center between January 2000 and July 2022. Demographic and medical history data were collected and compared between children with IF that developed chronic intestinal inflammation and children with IF that did not develop chronic intestinal inflammation. Results: During the follow-up period, 23 children were diagnosed with chronic intestinal inflammation. Of these, 12 (52%) were males, with a median age of 4.5 (3–7) years at diagnosis. Nearly one-third of the patients had gastroschisis (31%), followed by necrotizing enterocolitis (26%), and malrotation and volvulus (21.7%). More children in the chronic intestinal inflammation group lacked an ileocecal valve (ICV) and adjoining distal ileum as compared to the short bowel syndrome (SBS)-IF control group (15 patients, 65% vs 8 patients, 33%). Moreover, more children in the chronic intestinal inflammation group had undergone a prior lengthening procedure than the SBS-IF control group (5 patients, 21.7% vs. 0, respectively). Discussion: SBS patients are at risk of relatively early onset chronic intestinal inflammation. The absence of an ICV (and adjoin ileum) and prior lengthening procedures emerge as factors associated with the risk of IBD in these patients.

[1]  D. Figeys,et al.  Butyrate's role in human health and the current progress towards its clinical application to treat gastrointestinal disease. , 2022, Clinical nutrition.

[2]  R. Choudhury,et al.  Surgical Treatment of Short Bowel Syndrome—The Past, the Present and the Future, a Descriptive Review of the Literature , 2022, Children.

[3]  P. Wales,et al.  Management of pediatric intestinal failure related to short bowel syndrome. , 2022, Seminars in pediatric surgery.

[4]  J. van Praagh,et al.  Comparing bowel lengthening procedures: which, when, and why? , 2022, Current opinion in organ transplantation.

[5]  P. Wales,et al.  ASPEN definitions in pediatric intestinal failure. , 2021, JPEN. Journal of parenteral and enteral nutrition.

[6]  J. Hugot,et al.  A European Survey on Digestive Perianastomotic Ulcerations, a Rare Crohn-like Disorder Occurring in Children and Young Adults , 2021, Journal of pediatric gastroenterology and nutrition.

[7]  M. Pakarinen,et al.  Safety and Efficacy of Teduglutide in Pediatric Patients With Intestinal Failure due to Short Bowel Syndrome: A 24‐Week, Phase III Study , 2019, JPEN. Journal of parenteral and enteral nutrition.

[8]  P. Wales,et al.  Early Predictors of Enteral Autonomy in Pediatric Intestinal Failure Resulting From Short Bowel Syndrome: Development of a Disease Severity Scoring Tool. , 2019, JPEN. Journal of parenteral and enteral nutrition.

[9]  E. Rings,et al.  The Gut Microbiome in Patients with Intestinal Failure: Current Evidence and Implications for Clinical Practice , 2018, JPEN. Journal of parenteral and enteral nutrition.

[10]  K. Steinberg,et al.  Predicting Intestinal Adaptation in Pediatric Intestinal Failure: A Retrospective Cohort Study , 2017, Annals of surgery.

[11]  J. Srinivasan,et al.  Pediatric short bowel syndrome and subsequent development of inflammatory bowel disease: an illustrative case and literature review , 2017, Pediatric Surgery International.

[12]  V. Cohran,et al.  Redefining short bowel syndrome in the 21st century , 2017, Pediatric Research.

[13]  James Butcher,et al.  Altered intestinal microbiota–host mitochondria crosstalk in new onset Crohn's disease , 2016, Nature Communications.

[14]  J. Chambers,et al.  Ligand‐directed delivery of fluorophores to track native calcium‐permeable AMPA receptors in neuronal cultures , 2015, Journal of neurochemistry.

[15]  Se Jin Song,et al.  The treatment-naive microbiome in new-onset Crohn's disease. , 2014, Cell host & microbe.

[16]  G. Veres,et al.  ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents , 2013, Journal of pediatric gastroenterology and nutrition.

[17]  M. Dubinsky,et al.  Update in pediatric inflammatory bowel disease. , 2013, Rheumatic diseases clinics of North America.

[18]  J. Langer,et al.  Inflammatory bowel disease manifesting after surgical treatment for Hirschsprung disease. , 2012, Journal of pediatric gastroenterology and nutrition.

[19]  C. Romano,et al.  Dysbiosis in the Pathogenesis of Pediatric Inflammatory Bowel Diseases , 2012, International journal of inflammation.

[20]  Tetsuya Hayashi,et al.  Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. , 2011, Gastroenterology.

[21]  J. Doré,et al.  Intestinal Microbiota of 6-week-old Infants Across Europe: Geographic Influence Beyond Delivery Mode, Breast-feeding, and Antibiotics , 2010, Journal of pediatric gastroenterology and nutrition.

[22]  S. Forsythe,et al.  Neonatal enteral feeding tubes as loci for colonisation by members of the Enterobacteriaceae , 2009, BMC infectious diseases.

[23]  P. Wales,et al.  Establishing norms for intestinal length in children. , 2009, Journal of pediatric surgery.

[24]  T. Ziegler,et al.  Small bowel bacterial overgrowth in adults: A potential contributor to intestinal failure , 2007, Current gastroenterology reports.

[25]  P. A. van den Brandt,et al.  Factors Influencing the Composition of the Intestinal Microbiota in Early Infancy , 2006, Pediatrics.

[26]  S. Chari,et al.  Ileocolonic anastomotic ulcers: a case series and review of the literature , 2000, American Journal of Gastroenterology.

[27]  J. Zenel.  Failure to thrive: a general pediatrician's perspective. , 1997, Pediatrics in review.

[28]  G. Lovelace,et al.  Duodenal bile acids among children: keto derivatives and aerobic small bowel bacterial overgrowth. , 1987, Journal of pediatric gastroenterology and nutrition.

[29]  S. Weisdorf,et al.  Bacterial overgrowth in the small intestine , 1980 .

[30]  D. Teitelbaum,et al.  Anti-TNF-α treatment for post-anastomotic ulcers and inflammatory bowel disease with Crohn’s-like pathologic changes following intestinal surgery in pediatric patients , 2014, Pediatric Surgery International.

[31]  G. Weinstock,et al.  Small Bowel Resection Induces Long-Term Changes in the Enteric Microbiota of Mice , 2014, Journal of Gastrointestinal Surgery.

[32]  C. Hoyen.  Factors Influencing the Composition of the Intestinal Microbiota in Early Infancy , 2007 .

[33]  A. Buchman,et al.  Short bowel syndrome and intestinal failure: consensus definitions and overview. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.